Determining the coping strategies of individuals with epilepsy
Ramon Edmundo D Bautista1, Valerie Rundle-Gonzalez, Rusha G Awad
1Comprehensive Epilepsy Program, Department of Neurology, University of Florida Health Sciences Center/Jacksonville, 32209, USA. ramon.bautista@jax.ufl.edu
Purpose:
The purpose of the present study was to determine whether the coping styles of patients with epilepsy are associated with certain demographic, clinical, and psychosocial variables.
Methods:
A survey of 200 patients using several tests including the Brief-COPE was conducted.
Results:
Nine subscales of the Brief-COPE achieved acceptable internal consistency and were employed in study analysis. Using principal component analysis, six subscales correlated well with one another, representing engagement-type coping strategies. The other three also correlated well, representing disengagement-type strategies. As a group, our patients favored engagement-type strategies. On univariate analysis, increased age, being African-American, receiving disability benefits, and work status were associated with the use of engagement-type strategies, while on multiple linear regression, only age and race were independently associated. Low BMQ-S scores, low income level, and not driving were associated with the use of disengagement-type strategies both on univariate and multivariate analyses.
Conclusion:
Among patients with epilepsy, certain demographic and psychosocial variables are associated with particular coping styles.
Related Concept Videos
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...
Coping Strategies: Emotion Focused
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types
Lazarus's Cognitive Appraisal Theory
Primary Appraisal:...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...


